ACTIVE

Aboleris Holdco

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-5,8 M €
+25.4% YoY
Gross margin
-5,8 M €
+25.5% YoY
Equity
14,3 M €
+13.4% YoY

What does Aboleris Holdco do?

Aboleris Holdco is a Public limited company incorporated in 2023. Its registered office is in Charleroi.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0803.217.012
Incorporation
27/06/2023
Legal form
Public limited company
Registered office
Rue Antoine de Saint-Exupéry 14
6041 Charleroi · WallonieSee on map
Contributed capital
30 988 984,98 €
Latest accounts
31/12/2025
Contacts
2 public details availableLog in to view
Signals
Solid equityLow riskGood liquidity
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 3 financial years

202520242023
Income statement
Gross margin-5,8 M €-7,8 M €-3,2 M €
EBITDA-5,8 M €-7,8 M €-3,2 M €
Operating result-5,8 M €-7,8 M €-3,2 M €
Net result-5,8 M €-7,8 M €-3,1 M €
Balance sheet
Equity14,3 M €12,6 M €12,5 M €
Total assets14,8 M €13,3 M €13,1 M €
Cash888,4 k €3,3 M €1,8 M €
Debts509,8 k €667,1 k €619,6 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 6 active · 10 ended

Active mandates

Newton Biocapital Partners

Director · since 10 juin 2025 · until 28 février 2029 · 0673.852.565

Represented by Alain PARTHOENS

Active
Sound Bioventures Management AB

Director · since 10 juin 2025 · until 28 février 2030 · 5593100026

Represented by Casper BREUM

Active
Biotech Corporate dev

Director · since 22 janvier 2024 · until 28 février 2030

Represented by Frédéric LEGROS

Active
Criteria Bio Ventures SICC SA

Director · since 22 janvier 2024 · until 28 février 2030 · 0803.336.281

Represented by Pablo CIRONI LOPEZ

Active
SPARAXIS

Director · since 10 juillet 2023 · until 28 février 2029 · 0452.116.307

Represented by Caroline THIELEN

Active
A.L.M. Management & Consulting

Director · since 27 juin 2023 · until 28 février 2029 · 0534.683.596

Represented by Ann MEULEMANS

Active

Ended mandates

Bibhash MUKHOPADHYAY

Director · since 22 janvier 2024 · until 21 janvier 2030

Ended
Criteria Bio Ventures SICC SA

Director · since 22 janvier 2024 · until 28 février 2030 · 0803.336.281

Represented by Pablo CIRONI LOPEZ

Ended
Sound Bioventures Management AB

Director · since 22 janvier 2024 · until 28 février 2030 · 5593100026

Represented by Bibhash MUKHOPADHYAY

Ended
Biotech Corporate dev

Director · since 10 janvier 2024 · until 28 février 2030

Represented by Frédéric LEGROS

Ended
At this address

Other companies at this address

CompanyCBE no.
AEDAS● Active
0477.140.327
AIMIA PROPRIETARY LOYALTY BELGIUM● Liquidation
0412.386.392
ASSOCIATION VINCOTTE NUCLEAR● Active
0402.984.520
ATF BELGIUM● Active
0475.656.227
BMC PROPERTY BELGIUM● Active
0801.996.097
Cachoup Belgium● Active
0668.613.773
CONSORTIUM REAL ESTATE● Active
0462.347.530
CXC Global Belgium● Active
0753.434.731
DHETONA● Active
0766.287.825
DISTRICT TWELVE● Active
0757.726.188
EHFV BELGIUM● Active
1021.205.013
EIFFAGE REAL ESTATE WALLONIE● Active
0443.550.118
ENTREPRISE, FINANCEMENT & DEVELOPPEMENT● Active
0439.854.121
European Communication Research and Education Association● Active
0473.516.584
Financière de Soury Belgique● Active
0600.879.366
Globalization Partners Belgium● Active
0760.581.453
IMELCO● Active
0445.202.680
IMMABO● Active
0643.812.853
IMMOBILIERE SAINT-JOB● Active
0890.004.001
Innovation Path BE● Active
1023.261.908
Annual accounts

Full financial information

202520242023
Type of accountAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202427/06/2023
Closing of the financial year31/12/202531/12/202431/12/2023
Length of the financial year12 months12 months7 months
Filing date19/06/202606/05/202528/03/2024
General meeting12/05/202623/04/202529/02/2024
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

3 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202512/05/202619/06/2026FrenchPDF
Abridged model31/12/202423/04/202506/05/2025FrenchPDF
Abridged model31/12/202329/02/202428/03/2024FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 6 active · 10 ended

Active mandates

Newton Biocapital Partners

Director · since 10 juin 2025 · until 28 février 2029 · 0673.852.565

Represented by Alain PARTHOENS

Active
Sound Bioventures Management AB

Director · since 10 juin 2025 · until 28 février 2030 · 5593100026

Represented by Casper BREUM

Active
Biotech Corporate dev

Director · since 22 janvier 2024 · until 28 février 2030

Represented by Frédéric LEGROS

Active
Criteria Bio Ventures SICC SA

Director · since 22 janvier 2024 · until 28 février 2030 · 0803.336.281

Represented by Pablo CIRONI LOPEZ

Active
SPARAXIS

Director · since 10 juillet 2023 · until 28 février 2029 · 0452.116.307

Represented by Caroline THIELEN

Active
A.L.M. Management & Consulting

Director · since 27 juin 2023 · until 28 février 2029 · 0534.683.596

Represented by Ann MEULEMANS

Active

Ended mandates

Bibhash MUKHOPADHYAY

Director · since 22 janvier 2024 · until 21 janvier 2030

Ended
Criteria Bio Ventures SICC SA

Director · since 22 janvier 2024 · until 28 février 2030 · 0803.336.281

Represented by Pablo CIRONI LOPEZ

Ended
Sound Bioventures Management AB

Director · since 22 janvier 2024 · until 28 février 2030 · 5593100026

Represented by Bibhash MUKHOPADHYAY

Ended
Biotech Corporate dev

Director · since 10 janvier 2024 · until 28 février 2030

Represented by Frédéric LEGROS

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates16/09/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares14/04/2025
    CAPITAL, ACTIONS
    PDF
  • Mandates05/12/2024
    DIVERS - DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares25/04/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Mandates16/04/2024
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates28/07/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates20/07/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares12/07/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-5,8 M €↑
  2. 2024
    Annual accounts 2024-7,8 M €↓
  3. 2023
    Annual accounts 2023-3,1 M €
  4. 27/06/2023
    IncorporationPublic limited company